Axogen Net Worth
Axogen Net Worth Breakdown | AXGN |
Axogen Net Worth Analysis
Axogen's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Axogen's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Axogen's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Axogen's net worth analysis. One common approach is to calculate Axogen's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Axogen's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Axogen's net worth. This approach calculates the present value of Axogen's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Axogen's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Axogen's net worth. This involves comparing Axogen's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Axogen's net worth relative to its peers.
Enterprise Value |
|
To determine if Axogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Axogen's net worth research are outlined below:
| Axogen Inc generated a negative expected return over the last 90 days | |
| Axogen Inc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 144.29 M. | |
| Over 86.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: What analysts say about Axogen Inc. stock - Superior risk-adjusted returns - Jammu Links News |
Axogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Axogen Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Axogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Axogen's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Axogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Axogen Inc backward and forwards among themselves. Axogen's institutional investor refers to the entity that pools money to purchase Axogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wasatch Advisors Lp | 2025-03-31 | 774.6 K | Dafna Capital Management Llc | 2025-03-31 | 680.8 K | Balyasny Asset Management Llc | 2025-03-31 | 680.2 K | Marshall Wace Asset Management Ltd | 2025-03-31 | 668.3 K | Deutsche Bank Ag | 2025-03-31 | 591.3 K | Silvercrest Asset Management Group Llc | 2025-03-31 | 580.2 K | D. E. Shaw & Co Lp | 2025-03-31 | 562.4 K | Armistice Capital, Llc | 2025-03-31 | 538.3 K | Parkman Healthcare Partners Llc | 2025-03-31 | 536.8 K | First Light Asset Management, Llc | 2025-03-31 | 4.5 M | Blackrock Inc | 2025-03-31 | 3.6 M |
Follow Axogen's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 513.74 M.Market Cap |
|
Project Axogen's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.05) | (0.05) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.10) | (0.10) |
When accessing Axogen's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Axogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Axogen's profitability and make more informed investment decisions.
Evaluate Axogen's management efficiency
As of the 19th of July 2025, Return On Tangible Assets is likely to drop to -0.05. In addition to that, Return On Capital Employed is likely to grow to -0.02. At this time, Axogen's Asset Turnover is very stable compared to the past year. Axogen's management efficiency ratios could be used to measure how well Axogen manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.35 | 1.50 | |
| Tangible Book Value Per Share | 2.22 | 1.45 | |
| Enterprise Value Over EBITDA | 126.75 | 133.09 | |
| Price Book Value Ratio | 7.02 | 12.77 | |
| Enterprise Value Multiple | 126.75 | 133.09 | |
| Price Fair Value | 7.02 | 12.77 | |
| Enterprise Value | 770.5 M | 809 M |
At Axogen Inc, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 2.8795 | Revenue | Quarterly Revenue Growth 0.174 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Axogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Axogen Corporate Filings
8K | 20th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 11th of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 15th of May 2025 Other Reports | ViewVerify | |
| 30th of April 2025 Other Reports | ViewVerify |
Axogen Earnings per Share Projection vs Actual
Axogen Corporate Management
| Gregory Davault | VP Marketing | Profile | |
| Maria Martinez | Chief Human Resource Officer | Profile | |
| Lindsey CPA | Chief Officer | Profile | |
| CFA CPA | Chief Officer | Profile |
Already Invested in Axogen Inc?
The danger of trading Axogen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Axogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Axogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Axogen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.16) | Revenue Per Share | Quarterly Revenue Growth 0.174 | Return On Assets | Return On Equity |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.